ANAXIS PHARMA
Who is ANAXIS PHARMA?
Anaxis Pharma is an Australian Biotech company developing novel inhibitors / modulators of cell death, specifically necroptosis, an inflammatory form of programmed cell death. This process, involving both kinases and pseudokinases, is central to and dysregulated in chronic inflammatory disease. Targ...See more
Industry & Specialities
Others
Countries of Operation
Australia Indonesia
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2017 (9 years)
Address:
1G ROYAL PARADE, PARKVILLE; MELBOURNE, VICTORIA 3052, AU
Employees by Department
Key Decision Makers
Joanne Hildebrand
Senior Scientist, Advisor. Small molecule kinase inhibitors for Inflammatory Disease
Gregg Smith
Drug Development Advisor
Martine Keenan
Chief Executive Officer
Insight
Signals
At a glance- Operates in multiple countries
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
2employees
Senior
1employees
Non-managers
1employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has ANAXIS PHARMA been operating for?
- What is the funding status of ANAXIS PHARMA?
- Where is ANAXIS PHARMA's headquarter?
- What ANAXIS PHARMA's spending power?
- Does ANAXIS PHARMA have a presence in the domain it operates in?